BioArctic AB Class B(DE:B9A)
€27.84+-0.46 (+1.46%)
DE:B9A
BioArctic AB Class B financials statements
€27.84
At close:+-0.46 (+1.46%)
BioArctic AB Class B (B9A) Ratios
15 Followers
BioArctic AB Class B Ratios
DE:B9A's free cash flow for Q2 2026 was kr0.00. For the 2026 fiscal year, DE:B9A's free cash flow was decreased by kr-137.84M and operating cash flow was kr137.84M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.78 | 5.75 | 9.22 | 11.58 | 8.51 |
| Quick Ratio | 4.78 | 5.75 | 9.23 | 11.47 | 8.51 |
| Cash Ratio | 2.00 | 2.92 | 4.89 | 11.36 | 8.38 |
| Solvency Ratio | 1.70 | -0.71 | 1.78 | 0.05 | -0.98 |
| Operating Cash Flow Ratio | 2.75 | -1.80 | 2.48 | -0.45 | -1.39 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 1.88B | kr 793.92M | kr 1.01B | kr 748.78M | kr 752.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.00 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.02 | 0.06 | 0.00 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.02 | 0.06 | 0.00 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.24 | 1.13 | 1.09 | 1.14 |
| Debt Service Coverage Ratio | 30.28 | -82.58 | 654.50 | 5.34 | -126.13 |
| Interest Coverage Ratio | 36.10 | -123.59 | 666.60 | -13.53 | -166.73 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.93 | 0.63 | 0.06 | 0.12 | 0.19 |
| Net Debt to EBITDA | -0.72 | 2.78 | -2.05 | -197.60 | 6.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 97.04% | 89.51% | 85.45% | 67.44% | -137.91% |
| EBIT Margin | 68.44% | -72.92% | 44.94% | -4.65% | -603.44% |
| EBITDA Margin | 69.08% | -64.17% | 47.94% | 1.76% | -546.19% |
| Operating Profit Margin | 68.44% | -88.79% | 41.01% | -4.45% | -603.66% |
| Pretax Profit Margin | 62.81% | -73.64% | 44.88% | -4.89% | -607.07% |
| Net Profit Margin | 51.14% | -68.81% | 37.22% | -4.90% | -517.54% |
| Continuous Operations Profit Margin | 51.14% | -68.81% | 37.22% | -4.90% | -517.53% |
| Net Income Per EBT | 81.42% | 93.44% | 82.92% | 100.10% | 85.25% |
| EBT Per EBIT | 91.77% | 82.94% | 109.44% | 109.92% | 100.56% |
| Return on Assets (ROA) | 39.70% | -15.93% | 19.33% | -1.30% | -13.34% |
| Return on Equity (ROE) | 51.97% | -19.79% | 21.90% | -1.42% | -15.19% |
| Return on Capital Employed (ROCE) | 66.59% | -24.41% | 23.81% | -1.29% | -17.54% |
| Return on Invested Capital (ROIC) | 53.81% | -22.49% | 19.69% | -1.28% | -14.81% |
| Return on Tangible Assets | 39.70% | -15.93% | 19.30% | -1.30% | -13.32% |
| Earnings Yield | 3.72% | -1.00% | 0.97% | -0.05% | -1.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.97 | 1.21 | 2762.31 | 28.69 | 7.15 |
| Payables Turnover | 2.47 | 0.53 | 3.00 | 3.46 | 4.66 |
| Inventory Turnover | 0.00 | 0.00 | -401.91 | 9.91 | 0.00 |
| Fixed Asset Turnover | 24.09 | 2.66 | 19.79 | 6.47 | 0.69 |
| Asset Turnover | 0.78 | 0.23 | 0.52 | 0.27 | 0.03 |
| Working Capital Turnover Ratio | 1.43 | 0.28 | 0.69 | 0.30 | 0.03 |
| Cash Conversion Cycle | -95.19 | -379.58 | -122.41 | -56.00 | -27.30 |
| Days of Sales Outstanding | 52.38 | 302.88 | 0.13 | 12.72 | 51.03 |
| Days of Inventory Outstanding | 0.00 | 0.00 | -0.91 | 36.82 | 0.00 |
| Days of Payables Outstanding | 147.57 | 682.45 | 121.63 | 105.54 | 78.33 |
| Operating Cycle | 52.38 | 302.88 | -0.78 | 49.54 | 51.03 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 16.17 | -3.57 | 3.51 | -0.36 | -1.60 |
| Free Cash Flow Per Share | 16.05 | -3.87 | 3.43 | -0.50 | -1.64 |
| Dividend Paid and CapEx Coverage Ratio | 139.71 | -11.88 | 41.61 | -2.48 | -32.02 |
| Capital Expenditure Coverage Ratio | 139.71 | -11.88 | 41.61 | -2.48 | -32.02 |
| Operating Cash Flow Coverage Ratio | 32.47 | -5.83 | 62.20 | -3.15 | -8.85 |
| Operating Cash Flow to Sales Ratio | 0.72 | -1.23 | 0.50 | -0.14 | -6.07 |
| Free Cash Flow Yield | 5.16% | -1.94% | 1.28% | -0.19% | -1.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.91 | -99.75 | 103.00 | -2143.16 | -87.63 |
| Price-to-Sales (P/S) Ratio | 13.76 | 68.64 | 38.33 | 104.94 | 453.50 |
| Price-to-Book (P/B) Ratio | 13.99 | 19.74 | 22.56 | 30.47 | 13.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.36 | -51.50 | 78.12 | -539.75 | -72.47 |
| Price-to-Operating Cash Flow Ratio | 19.22 | -55.84 | 76.24 | -757.20 | -74.73 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 0.56 | -0.05 | 23.70 | -1.18 |
| Enterprise Value Multiple | 19.20 | -104.19 | 77.91 | 5754.25 | -76.44 |
| Enterprise Value | 26.51B | 17.20B | 23.01B | 23.16B | 9.66B |
| EV to EBITDA | 19.20 | -104.19 | 77.91 | 5754.25 | -76.44 |
| EV to Sales | 13.26 | 66.85 | 37.35 | 101.45 | 417.53 |
| EV to Free Cash Flow | 18.66 | -50.16 | 76.12 | -521.83 | -66.72 |
| EV to Operating Cash Flow | 18.53 | -54.39 | 74.29 | -732.06 | -68.81 |
| Tangible Book Value Per Share | 22.22 | 10.11 | 11.87 | 8.93 | 8.96 |
| Shareholders’ Equity Per Share | 22.22 | 10.11 | 11.87 | 8.93 | 8.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.07 | 0.17 | -0.00 | 0.15 |
| Revenue Per Share | 22.59 | 2.91 | 6.99 | 2.59 | 0.26 |
| Net Income Per Share | 11.55 | -2.00 | 2.60 | -0.13 | -1.36 |
| Tax Burden | 0.81 | 0.93 | 0.83 | 1.00 | 0.85 |
| Interest Burden | 0.92 | 1.01 | 1.00 | 1.05 | 1.01 |
| Research & Development to Revenue | 0.19 | 1.21 | 0.15 | 0.33 | 2.38 |
| SG&A to Revenue | 0.10 | 0.58 | 0.21 | 0.00 | 1.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.03 | 0.01 | 0.07 |
| Income Quality | 1.40 | 1.38 | 1.35 | 1.81 | 1.01 |
Currency in SEK
